secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2025-10-23T23:59:59+00:00
Accession:  0001567264-25-000096
Event type: other
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics shareholders approve reverse stock split ratio of 1:5 to 1:30
--------------------------------------------------------------------------------

- Reverse split proposal passed with 18,333,570 For, 4,508,502 Against, 27,490 Abstain.
- Adjournment proposal also approved: 18,869,741 For, 3,893,779 Against, 106,042 Abstain.
- Quorum of 22,869,562 shares (46.61% of outstanding common stock) was present at the 10/22/2025 Special Meeting.
- Board may set the exact ratio within 1:5 to 1:30 range or abandon the split entirely.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000156726425000096/0001567264-25-000096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000156726425000096/intensity-20251022.htm
  HTML page:      https://secwatch.observer/filing/0001567264-25-000096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer